STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $101,000 | +13.5% | 36,500 | 0.0% | 0.01% | +11.1% |
Q4 2020 | $89,000 | +58.9% | 36,500 | +37.7% | 0.01% | +12.5% |
Q3 2020 | $56,000 | +47.4% | 26,500 | +165.0% | 0.01% | +33.3% |
Q2 2020 | $38,000 | +100.0% | 10,000 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $19,000 | -9.5% | 10,000 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $21,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |